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Abstract
The majority of studies concerning malaria host genetics have focused on individual genes that confer protection against
rather than susceptibility to malaria. Establishing the relative impact of genetic versus non-genetic factors on malaria
infection and disease is essential to focus effort on key determinant factors. This relative contribution has rarely been
evaluated for Plasmodium falciparum and almost never for Plasmodium vivax. We conducted a longitudinal cohort study in a
Karen population of 3,484 individuals in a region of mesoendemic malaria, Thailand from 1998 to 2005. The number of P.
falciparum and P. vivax clinical cases and the parasite density per person were determined. Statistical analyses were
performed to account for the influence of environmental factors and the genetic heritability of the phenotypes was
calculated using the pedigree-based variance components model. The genetic contribution to the number of clinical
episodes resulting from P. falciparum and P. vivax were 10% and 19% respectively. There was also moderate genetic
contribution to the maximum and overall parasite trophozoite density phenotypes for both P. falciparum (16%&16%) and P.
vivax (15%&13%). These values, for P. falciparum, were similar to those previously observed in a region of much higher
transmission intensity in Senegal, West Africa. Although environmental factors play an important role in acquiring an
infection, genetics plays a determinant role in the outcome of an infection with either malaria parasite species prior to the
development of immunity.
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Introduction
Human malaria is caused by four species of erythrocyte-
invading plasmodial parasites, of which Plasmodium falciparum and
Plasmodium vivax are the most common. These two species co-exist
in many parts of the world including Thailand. Despite major
attempts over the past century to control malaria, this infection
remains the most important human parasitic disease worldwide. P.
falciparum is estimated to cause about half a billion episodes per
year [1], and there are hundreds of millions of cases due to P. vivax,
P. malariae and P. ovale. Malaria parasites are becoming
increasingly drug resistant and despite considerable effort over
the last decade, there is as yet no sight of an effective vaccine.
Human genetic resistant factors for malaria were first discovered
half a century ago, largely as a result of Haldane’s insight that
malaria was the likely evolutionary driving force behind common
erythrocyte variants in tropical populations [2]. The high gene
frequency of the sickle cell mutation (HbS) in Africa, which confers
protection against severe malaria in heterozygotes but causes fatal
sickle cell disease in homozygotes, illustrates the powerful selective
pressure exerted by malaria on the human genome. Since, b -
globin, and several other genes and genetic variants have been
shown to be involved in the protection against or susceptibility to
severe malaria, including a-globin, HLA and several cytokine loci
[3]. Most of the protective variants are thought to have emerged in
populations living in regions endemic for malaria as a result of the
high selection pressure exerted by the parasite [2,4–6]. In addition
to a demonstrated implication of such candidate genes, family-
based segregation and linkage analyses have repeatedly identified
the importance of the chromosomal region 5q31-33 in the control
PLoS ONE | www.plosone.org 1 December 2008 | Volume 3 | Issue 12 | e3887of parasite density, with heritability exceeding 40% [7–11]. This
region contains a cluster of cytokines, which may represent strong
candidate genes for control of malaria infection, but the causative
gene(s) and variant(s), remain to be identified. More recently, a
genome-wide linkage study found locus-specific heritability on
chromosome 13q for P. falciparum parasite density and chromo-
some 10p for the number of malaria episodes of approximately
35% [12]. This was suggested to support the conclusion that
susceptibility and resistance to infectious diseases be governed by
few major genes rather than many minor genes [13].
The ultimate goal of genetic epidemiology is to identify critical
molecular pathways of pathogenesis and immunity, thereby
generating novel strategies for treatment and prevention. Yet,
both Plasmodium infection and malaria disease are well known to be
strongly influenced by environmental factors. In addition, there
are human non-genetic factors such as age and gender that also
have a major effect on both incidence and outcome of infection.
Establishing the relative impact of genetic versus non-genetic
factors on infection and disease is essential to focus effort on key
determinant factors. This relative contribution has been rarely
evaluated [14–16], largely because of the difficulty in estimating
the overall contribution of genetic factors (heritability, h
2)i n
infection and disease. Estimation of heritability requires reliable
information on family structure and sufficient data on well-defined
malaria related phenotypes all the while controlling for heteroge-
neity in both the human genetic background and the force of
infection. Longitudinal community-cohort studies are thus re-
quired.
In this study, we have estimated the contribution of host genetic
factors to malaria relative to environmental factors in a Karen
population located near the Thai-Myanmar border, which is an
endemic area for P. falciparum and P. vivax malaria in Thailand.
Materials and Methods
Study site and family data
A community-based cohort study was carried out from June
1998 to May 2005. The study was conducted in a mountainous
area of Suan Phung district, Ratchaburi province, Thailand. Suan
Phung is a small district situated near the Thai-Myanmar border
surrounded by the long Tanaosri ranges on the western side. The
Tanaosri subdistrict is located at the southern part of Suan Phung,
approximately 163 km west of Bangkok. Suan Phung has a total
population of 5,368 living in 7 hamlets, of which 3,484 villagers of
all ages participated in the study. This community is made up of a
group of 4 closely related ethnic groups, the majority of which are
Karen (85%), some Thai (14%) and the rest are Mon and Burmese
(1%). The project protocol and objectives were explained to the
population and informed consent was individually obtained from
all subjects either by signature or by thumbprint on a voluntary
consent form written in Thai, the local language. Such consent
was obtained in the presence of the school director, an
independent witness. For very young children, parents or
designated tutors signed on their behalf. The recruitment
procedure has been previously detailed [17]. Ethical permission
for the study was granted by the Ethical Committee of the
Ministry of Public Health of Thailand.
Family structures were constructed by using a questionnaire,
interviewing each individual or key representatives of the
household to obtain both demographic information such as birth
date, age, sex, day of fever, and genetic relationships between
children, their parents, and sometimes their grandparents or non-
relatives in the same household, and other households. Pedigree
structures were checked in 928 individuals, from whom we
obtained DNA samples, by identity by state allele sharing of each
relative pair from genotyping results of 400 microsatellite markers
used during genome screening using IBS_check program (Heath,
unpublished). There was ,5% discordance including labelling
errors. Pedigrees were modified accordingly.
The total pedigrees are comprised of 2,427 individuals,
including absent or deceased relatives. There were 238 indepen-
dent families containing 603 nuclear families; the majority are 2
generation-families with family size range from 3 to 958 (Table 1).
For estimation of heritability, we used information from families
that had at least 2 members with the phenotypes of interest, which
varied according to occurrence of the diseases. The number of
families and relative pair counts for each phenotype category are
shown in Table 2.
Table 1. Family statistics.
Individuals characteristics
Sex: M/F ratio 1.03
Age median (min-max) yrs 14 (0–92)
Age group N %
,1 52 2.0
1–4 332 13.0
5–9 429 16.9
10–14 370 14.5
15–24 494 19.4
25–39 513 20.2
40–59 282 11.1
60+ 73 2.9
Family size: Number of Pedigrees
33 9
45 0
54 0
63 9
72 3
81 0
91 1
10 5
11 3
12 3
14 3
15 3
16 1
17 3
19 1
20 1
28 1
38 1
958 1
Number of Generations Number of Pedigrees
21 9 2
34 2
44
doi:10.1371/journal.pone.0003887.t001
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The epidemiology of malaria in this site has been described
elsewhere [17]. Briefly, the incidence of malaria is highly seasonal
with annual peaks in May-June and decreased over the duration of
the study from 141 per 1000 person-years in 1999 to 57 in 2004
for P. falciparum and from 79 to 28 for P. vivax. P. falciparum
prevalence rates varied from 1–7% seasonally and from 1–4% for
P. vivax. There was good concordance in the proportion of fevers
that were found to be positive for malaria parasites and the
fraction of fevers attributable to malaria. Thus, in this site, virtually
all infections lead to febrile episodes. Peak incidence occurred in
an earlier age group (5–9 years old) for P. vivax than for P.
falciparum (10–15 years old). Parasite densities of either species
peaked in the ,10 years old age group. Bed nets had no effect on
incidence rates.
Data Collection
The installation of a health clinic enabled passive case detection
of malaria episodes and a record of non-malaria presentation. We
defined clinical malaria episodes as measured fever (axillary
temperature.37.5 uC) or fever-related symptoms including head-
ache, back pain, chills, myalgia, nausea and vomiting associated
with a slide positive for blood-stage trophozoite P. falciparum, P.
vivax, P. malariae and P. ovale parasites at any density. To determine
the correct number of clinical episodes, consecutive presentation at
the clinic with blood-stage malaria parasite of the same species
within 30 days after treatment of the initial infection was
considered as the same episode. Consecutive presentation with
non-malaria fever (or aforementioned symptoms) within 7 days
following first presentation was likewise considered as the same
episode. In addition, initial parasite negative visits were considered
as part of a malaria episode if followed by a parasite-positive visit
within the subsequent two days. All positive malaria cases were
treated with appropriate antimalarial treatment according to the
recommendation of the Malaria Division, Ministry of Public
Health, as previously described [17]. Self-treatment is considered
to be rare in the study area, because the only other access to
treatment is a government clinic with which the study has good
communication concerning malaria treatment of the study site
population. In all cases parasite positivity was established as follows.
Thickandthinbloodfilmswerepreparedandstainedby3%Giemsa
stain.Blood films were examined under an oilimmersion objective at
61000 magnification by the trained laboratory technicians and 200
thick film fields were examined before films were declared negative.
Parasite species were identified on thin films and densities (per ml)
were calculated from thick film by establishing the ratio of parasites
to white blood cells (WBC) after at least 200–500 WBCs had been
counted and then multiplying the parasite count by 8,000, the
average WBC count per mlo fb l o o d .
Disease phenotypes
Two categories of malaria phenotypes were considered in the
study.
A. Clinical phenotypes. We studied the phenotypes related to
clinical malaria episode in 2 different ways. (1) As the number of
clinical visits that were positive for P. falciparum (Acronym PFA) or
P. vivax (PVA) or which were negative i.e. number of non-malaria
fever visits (Acronym NMF), (2) The proportion of visits that was
positive for P. falciparum (Acronym PPFA) or P. vivax (Acronym
PPVA). Using proportion in addition to number is an attempt to
take into consideration differing tendency to visit the clinic;
although virtually all malaria parasite infections are symptomatic,
individuals who tend to visit the clinic very frequently may present
with the few asymptomatic infections. In addition, this measure
provides an independent measure that implicitly takes into account
the time in the study.
B. Parasite biological phenotypes. For each species, we studied 2
different phenotypes related to parasite density during malaria
clinical attacks. (1) Maximum trophozoite density (Acronym
mx-PFD for P. falciparum and mx-PVD for P. vivax), (2) All
trophozoite parasite densities excluding zero parasite density
values i.e. excluding uninfected individuals (Acronym PFD for P.
falciparum and PVD for P. vivax). Maximum density was chosen to
assess whether there were individual human differences in the
control of parasite density independently of parasite genotype. ‘‘All
densities’’ was chosen to consider overall variation in the human-
parasite interaction, taking into account variation due to parasite
genotype.
Table 2. Summary of samples used in epidemiological and genetic analyses.
A. Clinical Phenotypes
B. Parasite Biological
Phenotypes
B. Parasite Biological
Phenotypes
Plasmodium falciparum Plasmodium vivax
Epidemiological analyses Data points 19,162 1,795 975
Individuals 2,545 949 517
Genetic analyses Individuals 2,018 (832) 857 (371) 470 (232)
Independent families 233 187 136
Sib-pairs 1,950 (977) 551 (299) 202 (133)
Halfsib-pairs 395 (292) 113 (86) 31 (26)
Cousin-pairs 2,414 (2,307) 554 (544) 363 (362)
Parent-Child-pairs 2,324 (1,110) 479 (267) 88 (49)
Grandparent-pairs 849 (676) 117 (100) 43 (43)
Avuncular-pairs 2,123 (1,859) 452 (420) 155 (140)
For epidemiological analyses, presented are the number of data points (observations and calculated mean/max values) analyzed for each phenotype category, the
corresponding number of individuals implicated and hence residual values generated. For genetic analyses, presented are the number of these individuals for whom
pedigree information was available and thus the number of independent families and relative pairs count for each phenotype in the heritability analyses. In
parentheses, the number belonging to the large complex family.
doi:10.1371/journal.pone.0003887.t002
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Table 3 gives a summary of the analyses and variables used for
each phenotype. Statistical analyses and model fitting were
conducted using the statistical package Genstat 7.1. All individuals
in the study protocol were included in the analyses, irrespective of
whether their family structure was known. From 3,484 partici-
pants, 939 never came to the clinic during the observation period,
and were, therefore, excluded from the analyses. Factors
influencing the maximum parasite density of either P. falciparum
or P. vivax were analysed by fitting a Generalized Linear Model
(GLM) with a Poisson error structure (loglinear regression). For
phenotypes with repeated measures for the same individual (i.e. all
phenotypes except maximum parasite density), a Generalized
Linear Mixed Model (GLMM) was fitted with individual person as
a factor in the random model. For number of episodes (non-
malaria, P. falciparum or P. vivax) and parasite density, a Poisson
error structure was implemented, thus yielding a loglinear
regression. For proportion of visits that were positive for either
species, a binomial error structure was implemented (thus a logistic
regression). Explanatory factors include year (1998-2005), month,
hamlet (7), and gender, with age factored into eight groups (,1, 1–
4, 5–9, 10–14, 15–24, 25–39, 40–59 and 60+ years of age). Age
was additionally refitted as a factor with two groups (,15 and
$15 years of age), and as a continuous variable, but both proved
less explanatory (lower adjusted r
2) than age defined as eight
groups. Initially a full model including all interactions possible was
fitted and then the model was refined to include only statistically
significant parameters and interactions. Inclusion of such interac-
tion terms was considered important as it has been reported on
numerous occasions that gender and age-specific behaviour can
influence exposure and this can vary locally depending on the
nature of the environment. Date was only considered as a main
effect and not as an interaction with the other variables (age,
gender, hamlet). The seasonality of malaria transmission in this
region varies annually and thus month was considered only via its
interaction with year (i.e. as a factor month-year). Analysing using
date as a factor with just four levels (trimesters) proved less
explanatory (lower adjusted r
2). Because the data were over-
dispersed a dispersion parameter was estimated. F-statistics in the
GLM and Wald statistics, which approximate to a x
2 distribution,
in the GLMM were established. In the analyses of the number of
non-malaria or parasite species episodes, the time in the study was
added as a weight; 89% of individuals were recruited from the
outset and 97% by the end of the first year. In the analyses of
maximum parasite density, the number of parasite density data
points per individual was used as a weight.
The residual variance not explained by the ‘‘environmental’’
factors was generated. Because a non-normal error distribution
was used, Pearson rather than standardized normal residuals were
generated. For the phenotypes concerning number and proportion
of episodes, the sum of the residuals per person were then
calculated and used in the genetic analysis. For ‘‘all parasite
densities’’, all residual values for any individual (who had repeated
parasite density measures) were then used in the genetic analysis.
Only phenotypes from individuals for whom family structure was
available were analysed for heritability.
Genetic and house data analysis
To determine the contribution of genetic factors to clinical
episodes and parasite density phenotypes, we evaluated the h
2 of
‘‘single value’’ phenotypes (number/proportion of cases and
maximum density values) by using the SOLAR software package
(version 2.1.4) [18]. SOLAR performs a variance components
analysis of family data that decomposes the total variance of the
phenotypes into components that are due to genetic (polygenic)
(h
2), individual or environmental (e
2) and house (c
2) effects. We
tested for the heritability of the phenotype by comparing likelihood
between the reduced model, where total variation is due to
environmental variation only, and the full model where total
variation is composed of environmental and genetic effects
Table 3. Percentage of variation in P. falciparum (Pf) and P. vivax (Pv) phenotypes explained by environmental factors (and their
interactions) in the statistical analyses.
Phenotype Acronym
Age
group Gender Hamlet Date Age.gender Age.hamlet gender.hamlet Age.gender.hamlet
%( p)% ( p)% ( p)% ( p)% ( p)% ( p)% ( p)% ( p)
A. Clinical Phenotypes
Number of visits Pf+ PFA 2.3 0.6 1.9 6.3 0.11 (0.009) 0.69 (0.001) 0.15 (0.003) 0
Proportion of visits
Pf+
PPFA 1.8 0.5 1.5 5.0 0.13 (0.027) 0.51 0.12 0.26 (0.041)
Number of non-
malaria fever visits
NMF 0.8 0.2 0.8 2.6 0.03 0.35 0.03 (0.025) 0.03
Number of visits Pv+ PVA 4.4 0.3 0.4 4.2 0.3 (0.003) 1.4 0.2 (0.027) 0
Proportion of visits
Pv+
PPVA 3.5 0.2 0.4 3.3 0.2 (0.003) 1.1 0.14 (0.027) 0
B. Parasite Biological Phenotypes
Pf max parasite
density
mx-PFD 17.7 0.5 (0.022) 0.8 (0.014) 10.1 0 2.0 (0.004) 0 0
Pf parasite densities PFD 11.2 007.2 00 0 0
Pv max parasite
density
mx-PVD 6.2 0 0.6 (0.12
a) 8.8 0 5.1 (0.003) 0 0
Pv parasite densities PVD 3.3 0 3.0 (0.001) 5.9 (0.011) 0 0 0 0
In parentheses, p is the p-value; in bold, p-value,10
23.
aRetained because of significant interaction with Age.
doi:10.1371/journal.pone.0003887.t003
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individuals. When the null hypothesis was rejected, heritability (h
2)
was then estimated as the percentage of genetic variance of the
total. Although SOLAR can additionally incorporate measured
covariates (e.g. explanatory variables), a normal distribution is
assumed. For this reason we took into account the contribution of
such variables in an initial statistical analysis (section above) and
generated residual value for the phenotypes. The relative
contribution of genetic factors to phenotype variation is then
estimated by the heritability (h
2), defined by the ratio of genetic
variance component to the residual phenotypic variance [18]. As
several phenotypes showed residual kurtosis of more than 0.8, tdist
option, which creates an extra parameter in the model to describe
the distribution of the phenotype, was applied in all analyses. An
additive model, which is a general model, making no assumptions
of the dominant or recessive nature of the gene, was used to avoid
multiplying tests.
Household can confound the estimation of the genetic
contribution to a trait, because related individuals often live in
the same house. A household or shared environment effect can be
added by an additional variance component with a coefficient
matrix (H) whose elements (house) are 1 if the relative pair in
shares the environmental exposure or 0 otherwise. Genetic effect
(i.e. heritability) is estimated using matrix of correlation coefficients
for identity by descent (IBD) allele sharing in various types of
family relative pairs, whose elements (phi2) provide the predicted
proportion of genes of the whole genome that a pair of individuals
share at least 1 allele [18]. Table 4 shows the relationship of the
house elements and phi2 elements. Even for the most closely
related individual pairs (full sibs, parent-offspring), 38% live in
different houses. In SOLAR we first included the house effect in
the model. If the house effect was not significant (p value.0.05),
we excluded it from the model for estimation of heritability.
For the phenotypes for which there were multiple residual
values (i.e. parasite densities for both P. falciparum and P. vivax), we
evaluated heritability by using the classic repeated measures model
(from the ‘‘animal model’’) [19], where a permanent environmen-
tal effect is created for each individual. Thus the following model is
fitted: y=[Xb]+Za+Zpe+Zh+e where y is the residual parasite
density value, b is the fixed effects vector (here already taken into
account in the first statistical analysis), a is the additive genetic
effects vector, pe is the permanent environment effects vector (of
each individual), h is the common house effect vector and e is the
residual effects vector; 6is the design matrix relating observations
to fixed effects and Z are design matrices relating observations to
random effects. The model was fitted using ASREML vers. 2 [19].
The total phenotypic variance is therefore VP, which is partitioned
into VA, additive genetic variance, VPE, variance due to
permanent environmental effects, VH, common-house variance
and VR, residual variance. Heritability (h
2) is again VA/VP.
Genotyping
Microsatellite Genotyping. DNA was extracted from
10 mL venous blood or 0.5 mL capillary samples and randomly
amplified using a primer extension pre-amplification method [20].
Genotyping of microsatellites (Linkage Mapping Set v2.5- MD10)
was carried out using a ABI377 system (Applied Biosystems, Foster
City, USA). The microsatellite genotyping results were here used
for pedigree verification.
Genotyping results were checked for excess homozygotes or
excess heterozygotes assuming Hardy-Weinberg equilibrium.
Markers that showed excessive homo- or heterozygosity were re-
examined. Mendelian inheritance within families was confirmed
using the PedCheck program [21] and inconsistencies resolved by
re-examination of the raw data and re-genotyping where
necessary. After Mendelian inheritance was resolved, unlikely
genotypes were detected by the program MERLIN [22].
Suggested microsatellite genotyping errors were corrected by re-
examination of the raw data and re-genotyping where necessary.
Duffy blood group negative mutation (the DuffyT-
46C). We genotyped the Duffy T-46C SNP (rs2814778) [23]
by TaqMan assay using ABI Prism 7000 Sequence Detection
System with recommended protocol (TaqMan Universal Master
Mix, 1 ng genomic DNA, 16primer and probe mix). Primers and
probes were Duffy F primer: CTGATGGCCCTCATTAGTCC
TT, Duffy R primer: GCTGGGACGGCTGTCA, Duffy T allele:
59VIC–CTTCCAAGATAAGAGCC, Duffy C allele: 59FAM–
CCAAGGTAAGAGCC.
Table 4. Number of pairs of individuals as defined by genetic relationship (phi2) and household relationship.
phi2 house Total Relationships
0 (not shared) % 1 (shared) %
0 448758 99.9 494 0.1 449252 Unrelated
0.625 0 0 2 100 2 Parent offspring from inbred family
0.5 2065 38.3 3331 61.7 5396 Full-sibs, parent offspring
0.375 3 50 3 50 6 Half-sib and first cousin, half-sib and half-avuncular
0.3125 2 100 0 0 2 Half-sib and half-first cousin
0.25 3974 92 344 8 4318 Half-sibs, avuncular, grandparent, first cousin
0.1875 14 100 0 0 14 First cousin, once removed from inbred family
0.125 3788 98.4 61 1.6 3849 First cousin, half-avuncular, grand-avuncular
0.09375 1 100 0 0 1 Second cousin from half-sib marriage
0.0625 1829 99.8 3 0.2 1832 Half-first cousin, half-grand-avuncular, great-grand-avuncular,
great-great grandparent
0.03125 505 100 0 0 505 Second cousin
0.015625 8 100 0 0 8 Half-second cousin
Total 460947 99.1 4238 0.9 465185
doi:10.1371/journal.pone.0003887.t004
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From 1998 to 2005 (7 years) there were 19,162 independent
clinical presentations by 2,545 individuals (Range 1–51 per
person; mean 7.5 and median 5). Of these 2,430 were positive
for P. falciparum, presented by 1,120 individuals (Minimum of 1
and a maximum of 13 positive presentations per person; mean 2.2
and median 1.5). There were 1,280 cases of P. vivax, presented by
636 individuals (Minimum of 1 and a maximum of 13 positive
presentations per person; mean 2.0 and median 1), 30 cases of P.
malariae and 11 cases of P. ovale. There were reliable P. falciparum
trophozoite density data for 1,795 slides from 949 individuals and
for 975 slides from 517 individuals for P. vivax; mixed infections
were excluded. Only 38 P. falciparum-P. vivax and 3 P. falciparum-P.
malariae mixed infections were observed. A total of 3,710 infections
by any malaria parasite spp. were presented by 1,370 individuals
presented with infection at any time over the period of study.
Of the 2,304 individuals for whom family structure was
established, 2,018 came at least once to the clinic presenting a
total of 16,926 visits. There were 2,179 cases of P. falciparum
presented by 996 individuals and 1,118 cases of P. vivax by 555
individuals. There were 36 mixed P. falciparum-P. vivax infections
and 3 mixed P. falciparum-P. malariae infections. Excluding mixed
species infections, trophozoite density data was available for 857
individuals for P. falciparum and 470 for P. vivax. Table 2 records
the samples used for the statistical analyses and the number for
whom pedigree information was available and hence used for the
heritability analyses. Table 3 shows the significant ‘‘environmen-
tal’’ factors in the statistical analyses from which residual values
were generated for use in the heritability analyses and presents the
percentage of variation explained for the given phenotype by each
environmental variable. Date and age group have notably
important influence on malaria parasite phenotypes.
Correlation between phenotypes studied
Table 5 shows pair-wise correlation between the phenotypes
studied. Of particular interest are (i) Number of non-malaria fever is
strongly negatively correlated with the number of presentations with
either Plasmodium spp. and has a higher negative correlation
coefficient with the number of clinical P. falciparum attacks (R=
20.78) than of P. vivax (R= 20.43), (ii) Number of clinical P. vivax
attacks shows a highly significant positive correlation with maximum
or overall P. falciparum parasitemia (R = 0.12 and 0.05, p= 0.0003
and 0.005 respectively) but negligible or no significance with P. vivax
parasite density phenotypes (Maximum: R = 0.1 p= 0.02, not
significant after Bonferroni’s correction and overall: R=0.07 p=
0.25), (iii) Maximum P. falciparum density shows a positive correlation
with maximum P. vivax density (R = 0.22, p=0.0002). Not
surprisingly, the proportion of presentations with P. falciparum were
very strongly correlated with the number of presentations with P.
falciparum (R.0.90) and yielded very similar results in the statistical
analyses. The same was true for P. vivax. These two proportional
phenotypes yielded no additional information and were thus later
removed from the final correlation analyses to reduce the overall
number of pair-wise comparisons made.
Estimation of heritability and house effect (Table 6)
Clinical phenotypes. Heritabilities (h
2) of the number of
clinical cases of P. falciparum and P. vivax were 12.4% (s.e. 5.7) and
20.8% (s.e. 3.6) respectively. There was a significant house effect
for the number of clinical cases of P. falciparum (4.6% P=0.05) but
not for P. vivax. Similar values were obtained when considering the
proportion rather than the number of all visits that were due to P.
falciparum and P. vivax. The total number of non-malaria visits was
greatly influenced by house (8.7%, P=7610
24) but not
significantly so by genetics (6.5%, P=0.09). Exclusion of house
from the heritability analyses increased the genetic contribution to
the number of P. falciparum cases to 19.7% and to the number of
non-malaria cases to 18%.
Parasite biological phenotypes. There was moderate
heritability of parasite trophozoite density phenotypes for both
P. falciparum (Max. 23.7% and overall 20.4%) and P. vivax (19.1%
and 14.9%). There were no effects of house on these phenotypes.
Genetic and environmental contributions to parasite-
related phenotypes. We have partitioned the total variation in
the number of clinical malaria and parasite density phenotypes
into its genetic, house and environmental components (Tables 3&6
and Figure 1). Of particular interest are (i) the significant effect of
house on clinical P. falciparum phenotypes but the insignificant
effect on clinical P. vivax phenotypes, (ii) the higher genetic effect
for P. vivax clinical phenotypes than for P. falciparum and (iii) the
very strong effect of age on P. falciparum parasite density.
Screening for Duffy negative blood group. We screened
for Duffy negative blood group using polymorphism (DuffyT-46C)
[23] in 377 unrelated individuals and did not find any allele
associated with Duffy negative blood group phenotype in this
population. Thus there is only a 2% probability of not finding the
mutant allele if it is present at a frequency of only 1%.
Discussion
Our clinical malaria longitudinal cohort study, conducted in the
western province of Thailand, focused on analyses of the number
Table 5. Pair-wise correlation between phenotypes studied.
Phenotype
Acronym PFA NMF PVA mx-PFD PFD
mx-
PVD
NMF 20.78 corr coef.
,10
24 p-value
2544 n
PVA 0.003 20.43 corr coef.
0.88 ,10
24 p-value
2544 2544 n
mx-PFD 0.08 20.12 0.12 corr coef.
0.14 0.0002 0.0003 p-value
949 949 949 n
PFD 20.06 20.002 0.05 0.59 corr coef.
0.81 0.08 0.005 ,10
24 p-value
949 949 949 949 n
mx-PVD 0.02 20.12 0.10 0.22 0.11 corr coef.
0.71 0.0049 0.021 0.0002 0.014 p-value
517 517 517 285 285 n
PVD 0.10 20.15 0.07 0.17 0.10 0.63 corr coef.
0.58 0.1 0.25 0.002 0.01 ,10
24 p-value
517 517 517 285 285 517 n
PFA, Number of visits Pf+; NMF, Number of non-malaria fever visits; PVA,
Number of visits Pv+; mx-PFD, Pf max parasite density; PFD, Overall Pf parasite
densities; mx-PVD, Pv max parasite density; PVD, Overall Pv parasite densities. In
bold, highly significant p value (#10
24); in italic, significant p value that
becomes not significant after Bonferroni correction for multiple testing (21
hypotheses tested).
doi:10.1371/journal.pone.0003887.t005
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vivax after controlling for environmental effects. For all malaria
phenotypes considered, with the exception of P. falciparum
maximum parasite density, genetic effects explained more of the
phenotypic variability than any environmental effect. The parasite
species-specific genetic contributions varied according to the
phenotype, but were similar for both species. Although direct
comparison of genetic contributions between sites is confounded
by the differing importance of environmental factors, it is notable
that the total variation in number of malaria species episodes
explained by host genetic factors was similar in both this study and
the previous study in Sri Lanka [15]: 10% and 19% of the total
variation in the number of clinical P. falciparum and P. vivax
episodes respectively, compared to 15% for either species in Sri
Lanka. Moreover, the host genetic contribution to P. falciparum
parasite density was similar in both sites; only the genetic
contribution to P. vivax parasite density was found to be different
here (13%) as compared to 0% in Sri Lanka.
Table 6. Contribution (%) of genetic (heritability, h
2) and house (c
2) effects to variability in malaria and non-malaria clinical and
biological phenotypes of P. falciparum (Pf) and P. vivax (Pv).
Phenotype Acronym N Genetic effect House effect
h
2 (S.E.), p-value c
2 (S.E.), p-value
A. Clinical phenotypes
Number of visits Pf+ PFA 2018 12.4 (5.7), 0.009 4.6 (2.9), 0.05
a
Number of non-malaria fever visits NMF 2018 NE, NS 8.7 (2.9), 7 610
24
Number of visits Pv+ PVA 2018 20.8 (3.6), 4.6 610
24 NE, NS
B. Parasite biological phenotypes
Pf max parasite density mx-PFD 857 23.7 (7.9), 1.5 610
24 NE, NS
Pf parasite densities PFD 857 20.4 (4.3) NE, NS
Pv max parasite density mx-PVD 470 19.1 (10.5), 0.02 NE, NS
Pv parasite densities PVD 470 14.9 (4.6) NE, NS
h
2, variance due to genetics, c
2, variance due to house effect, S.E. the standard error; NS, not significant (p-value.0.05); NE, not estimated.
aRetained because of marginal significance.
doi:10.1371/journal.pone.0003887.t006
Figure 1. Proportions of variation explained by genetic heritability, house and environmental factors found to have a significant
effect on the phenotype measured (Table 3&6). (A) Number of clinical episodes of P. falciparum (PFA); (B) Number of clinical episodes of P. vivax
(PVA); (C) Number of non-malaria clinical episodes (NMF); (D) Maximum P. falciparum parasite density (mx-PFD); (E) Overall P. falciparum parasite
density (PFD); (F) Maximum P. vivax parasite density (mx-PVD); (G) Overall P. vivax parasite density (PVD). Values of 1% or less not indicated
numerically in the figure.
doi:10.1371/journal.pone.0003887.g001
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importance of house as a covariate. In the Sri Lanka study, house
had a more significant influence on P. vivax than on P. falciparum.I n
our study, there was only a marginal effect of house on P. falciparum
and no effect on P. vivax. Such clustering of P. falciparum cases has
been previously observed in Thailand [24], Sri Lanka [15] and
Africa [16,25]. The generally weaker effect of house here
compared with Africa in particular [16] most likely reflects the
different mosquito biting behaviour of the major vector species. In
Africa, Anopheles gambiae and An. funestus are predominantly
endophilic, whereas the major vectors here, An. maculatus and An.
minimus, are exophilic. House structure and proximity to mosquito
breeding and resting sites would therefore be expected to be less
important in Thailand than in Africa.
The absence of clustering of P. vivax cases suggests that some
additional factor impacts upon P. vivax compared with P. falciparum.
Differential Plasmodium species-specific vectorial competence and
behaviour could result in differences in house clustering. An
alternative explanation may reflect malaria species interactions.
The capacity of one Plasmodium species to suppress another within
the human is to some extent dependent on the infection status of
each species, where both P. falciparum and P. vivax can dominate
the infection. However, P. falciparum generally dominates when
present [26,27]. In this study site, a large number of P. vivax cases
occurred following treatment of P. falciparum [17], as has been
previously found in Thailand [28]. Thus P. vivax infections may be
likewise clustered but do not become patent because of suppression
by P. falciparum. The overlapping age-incidence curves of both
parasite species observed here may generate more potential for
species interactions than in Sri Lanka where peak incidence of
disease does not overlap.
The strong negative correlation between the number of non-
malaria fevers (NMF) and P. falciparum cases (PFA) suggests that
illness due to non-malaria pathogens may protect from P.
falciparum infection or disease and vice versa. The incidence of both
diseases is concentrated annually in a very short time span, thus
enabling such negative interactions. This is unlike the annual
distribution of P. vivax cases (PVA) that is less concentrated into
one peak, most probably because of its ability to relapse; this could
then explain the lower negative correlation of PVA with NMF.
The positive correlation between the number of P. vivax episodes
(PVA) and P. falciparum parasite density, especially maximum
density (mx-PFD) (and to a lesser extent between PVA and mx-
PVD) suggests that common mechanisms are involved in
determining these phenotypes. To investigate this, we examined
the effect of having a P. vivax episode during the first three years of
study on the mx-PFD for each corresponding individual during the
last 4 years of the study, taking into account environmental
parameters. Those previously infected with P. vivax (1998–2000)
had higher mx-PFD in 2001–2004 (P,0.001). They also had a
greater number of P. vivax episodes (P,0.001), but did not have
significantly different mx-PVD from those not previously infected
with P. vivax (P=0.16). This suggests that common mechanisms do
govern susceptibility to infection by P. vivax and control of P.
falciparum density but not control of P. vivax density. There was,
however, a strong positive correlation between maximum P. vivax
parasite density (mx-PVD) and mx-PFD. Given the differences in
red blood cell (rbc) tropism (reticulocytes for P. vivax and all rbc
types for P. falciparum), although blood disorders may be
implicated, the involvement of shared immunological mechanisms
is likely. It has been suggested that the two species may negatively
impact upon one another through the development of cross-
species immunity [29] and there is evidence for species-
transcending parasite density-dependent immune responses
[30,31]. Parasite density phenotypes were not influenced by house
in Thailand, consistent with the hypothesis that although house
can contribute to the tendency to become infected, it does not
impact upon the parasite once the infection has started. For both
species environment plays a relatively larger role in determining
the probability of infection, and genetics in determining the
outcome of infection.
To our knowledge, the only known human genetic influence on
resistance to P. vivax infection is the effect of Duffy blood group
antigen on the inability of P. vivax merozoites to invade Duffy
negative red blood cells [32,33]. The Duffy negative blood group
is mostly found in West Africa [34]. However, emergence of the
same null allele mutation (T-46C) [23] but on a different
haplotype was reported in Papua New Guinea and which affects
expression of the Duffy blood group [35] and leads to reduced P.
vivax erythrocyte infection [36]. We could not identify this
mutation in 377 unrelated individuals in our population. This
screening gave the probability of 0.0005 to have this mutation at a
frequency of 0.02 in our population (frequency found in Papua
New Guinea). It is thus unlikely that this mutation is responsible
for the genetic contribution found for P. vivax in this study,
although we cannot exclude other mutations in DARC gene coding
for Duffy blood group. Other inherited blood disorders occurring
regionally, such as the thalassemias, HbE and Glucose-6-
Phosphate Dehydrogenase may be involved in determining
susceptibility to P. vivax infection (and P. falciparum parasite
density). Numerous population studies have confirmed the
important protective role of such genetic disorders [5,6,37], but
have concentrated on severe malaria and P. falciparum even when
studied in South-East Asia [38].
A recent study on heritability of P. falciparum phenotypes in
Senegal found that parasite density was under a similar genetic
effect to PFA (h
2 21% vs. 28%) [39]. Here we again find a similar
genetic effect on density and number of attacks (h
2 20% vs. 20%
[excluding house effect]). The similarity of these values is all the
more remarkable given the very differing transmission intensities
observed in the two areas and differing human genetic background
(i.e. ethnicities). The marginally lower heritability of number of
episodes in this study site likely reflects lower transmission intensity
that has lead to increased heterogeneity in exposure. The
difference in the contribution of genetics is, however, small given
the very large difference in transmission intensity. The statistical
analyses that take into account environmental factors prior to
genetic analyses seemingly effectively account for differences in
transmission heterogeneity (risk of being infected). The high
similarity of the genetic contributions to the parasite density is
independent of acquired immunity, accounted for by use of age. It
should be noted, however, that there may be a genetic
contribution to acquired immunity, as previously shown [40,41],
that we have not considered here. Exclusion of acquired immunity
therefore focuses on the genetic contribution exerted through
innate immunity pathways and red blood cell mutations known to
have an impact on the parasite. The latter have been the subject of
considerable study and major mutations differ in the Thailand and
Senegal [3,42]. It is therefore striking that despite such known
differences, the heritability of parasite density should be so similar.
Finally, it is important to note that we estimated only the
additive genetic effect. The non-additive genetic effect may have
an important contribution to overall estimates of heritability.
However, the study population is inbred, which could lead to bias
in estimation of non-additive genetic effect: the chance to be
homozygous at particular regions of the genome is higher than
under panmixia. In addition, positive selection could lead to an
increase in frequency of some polymorphisms or mutations, which
Heritability of Malaria
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estimated.
In conclusion, our study clearly shows that there are major
human genetic effects influencing both clinical response to
infection and parasite parameters describing the infection status
of both P. falciparum and P. vivax. Although environmental factors
also play some role, their importance varies according to the
infection phenotype considered. Environment does seemingly play
an important role in acquiring an infection, but genetics plays a
determinant role in the outcome of an infection with either
malaria parasite species prior to the development of immunity.
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